8 results on '"Lymphoepithelioma-Like Hepatocellular Carcinoma"'
Search Results
2. Metastatic Lymphoepithelioma-like Hepatocellular Carcinoma: a Potential Diagnostic Pitfall and Demonstration of Pd-l1 Expression.
- Author
-
Putra, Juan, Anderson, Todd A., Roayaie, Sasan, Maeda, Miho, and Thung, Swan N.
- Subjects
LIVER cancer ,MEDICAL care ,TUMORS ,LYMPHOMAS ,GENE expression - Abstract
Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a rare primary hepatic neoplasm with female predominance and relatively good prognosis. We report a 73-year-old female with chronic hepatitis B who developed metastatic lesions 5 years after underwent resection for LEL-HCC. The metastatic lesions showed a spectrum of morphologic findings, which could be mistaken for other entities such as lymphoma, particularly in lesions with single-cell infiltrative pattern and abundant tumor-infiltrating lymphocytes. Immunohistochemical study to confirm the origin of the neoplastic cells is important to make the diagnosis. We also highlighted the clinicopathologic correlation and potential therapeutic implication of programmed death ligand-1 expression in LEL-HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver
- Author
-
Shih, En-Jie, Chau, Ivy Yenwen, Yeh, Yi-Chen, and Chau, Gar-Yang
- Subjects
Carcinoma, Hepatocellular ,Liver Neoplasms ,hepatocellular carcinoma ,digestive system diseases ,lymphoepithelioma-like hepatocellular carcinoma ,Hepatitis B, Chronic ,lymphoepithelioma-like carcinoma ,Humans ,Keratins ,chronic hepatitis B ,Female ,Clinical Case Report ,neoplasms ,Research Article ,Aged - Abstract
Rationale: Most cases of primary liver cancer involve hepatocellular carcinoma (HCC). Lymphoepithelioma-like carcinoma (LELC) is defined as a tumor composed of undifferentiated epithelial cells with a prominent lymphoid infiltrate, which is rarely reported. Lymphoepithelioma-like HCC (LEL-HCC) is an uncommon variant of HCC, having an unclear process of development. Here, we report the first case involving simultaneous HCC and LEL-HCC. Patient concerns: A 77-year-old female was accidentally found to have a hypoechoic hepatic nodule via an abdominal ultrasound during a health examination. Abdominal computed tomography scan revealed 2 hepatic nodules with arterial phase enhancement and washout in the late phase. Diagnoses: We diagnosed the case with 2 distinct liver nodules, HCC and LEL-HCC. Interventions: With suspicion of HCC, tumor resection (liver segments 4 and 5) was then performed. Histopathological examination of tumor 1 showed a moderately differentiated HCC and tumor 2 demonstrated a LEL-HCC. Immunohistochemically, the cells of tumor 2 were immunoreactive for cytokeratin (CK), CK7, and CK19. Epstein–Barr virus encoding small RNA (EBER) in situ hybridization results were negative. Outcomes: Six months after resection, intrahepatic tumor recurrence was noted. Radiofrequency ablation was conducted. Lessons: This is an interesting case providing circumstantial evidence of simultaneous development of HCC and LEL-HCC in distinct nodules of the liver with a background of chronic hepatitis B virus infection.
- Published
- 2018
4. Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma.
- Author
-
Hermel DJ, Du EZ, Lin R, Frenette CT, and Sigal DS
- Abstract
Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a very rare neoplasm, with distinct epidemiologic, morphologic and clinical characteristics. Molecular mechanistic insight into the pathogenesis of this carcinoma suggests a pivotal role for the host immune system in the proliferation and progression of this tumor. However, while detailed genomic profiling of these hepatic tumors have revealed an intra-tumoral inflammatory mutational signature that may predispose to immune checkpoint inhibitor efficacy, no published report has described their use in this tumor type. Unfortunately, with near 100 cases of LEL-HCC reported in the literature to date and the majority of cases confined to localized and resectable disease, current evidence-based practices in the unresectable setting are lacking, with unknown benefit of chemotherapy or immunotherapy. We report on the case of a 68 year-old man with unresectable, advanced LEL-HCC who had evidence of disease stability after starting on the immune checkpoint inhibitor nivolumab. His disease response persisted off therapy for over a year and was potentially augmented by radiotherapy at the site of local progression. For this extremely rare tumor subtype, this case highlights the potential efficacy and safety of immune checkpoint blockade in LEL-HCC and reinforces the need for more robust, large-scale analysis of patients with these rare tumors to better evaluate treatment strategies and outcomes., Competing Interests: The authors have no conflict of interests related to this publication., (© 2021 Authors.)
- Published
- 2021
- Full Text
- View/download PDF
5. Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature
- Author
-
Pinuccia Faviana, Luca Pollina, Laura Coletti, Paolo De Simone, Franco Filipponi, Andrea Cacciato Insilla, and Daniela Campani
- Subjects
Pathology ,Hepatocellular carcinoma ,medicine.medical_treatment ,Biopsy ,Case Report ,Gastroenterology ,Neoplasms, Multiple Primary ,Multiple Primary ,Neoplasms ,Lymphoepitheliomalike ,80 and over ,Needle ,Lymphocytes ,Chronic ,Tomography ,Aged, 80 and over ,Tumor ,GiST ,Biopsy, Needle ,Liver Neoplasms ,General Medicine ,Lymphoepithelioma ,Gastrointestinal stromal tumors ,Biomarkers, Tumor ,Carcinoma, Hepatocellular ,Epithelial Cells ,Female ,Gastrointestinal Stromal Tumors ,Hepatectomy ,Hepatitis C, Chronic ,Humans ,Immunohistochemistry ,Stomach Neoplasms ,Tomography, X-Ray Computed ,Hepatitis C ,X-Ray Computed ,medicine.symptom ,Lymphoepithelioma-Like Hepatocellular Carcinoma ,medicine.medical_specialty ,Lesion ,Internal medicine ,medicine ,neoplasms ,Aged ,business.industry ,Carcinoma ,Histology ,Hepatocellular ,medicine.disease ,digestive system diseases ,business ,Biomarkers - Abstract
Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a rare form of undifferentiated carcinoma of the liver characterized by the presence of an abundant lymphoid infiltrate. Here, a case of LEL-HCC is described. An 81-year-old woman with a chronic hepatitis C infection was referred to the general surgery department of our hospital in August 2013 with a diagnosis of HCC. A past ultrasound examination had revealed a 60 mm-diameter nodular lesion in the third segment of the liver. After a needle biopsy, the lesion was diagnosed as HCC. The patient underwent surgery with a liver segmentectomy. Two additional nodes on the gastric wall were detected during the surgical operation. The histology of the removed specimen showed a poorly differentiated HCC with significant lymphoid stroma. Immunohistochemical studies revealed that the epithelial component was reactive for CK CAM5.2, CK8, CK18, CEA (polyclonal) and was focally positive for hepar-1 and that the lymphoid infiltrate was positive for CD3, CD4 and CD8. The tumor cells were negative for Epstein-Barr virus. The gastric nodes were ultimately determined to be two small gastrointestinal stromal tumors (GISTs). The synchronous occurrence of HCC and GIST is another very uncommon finding rarely described in the literature. Here, we report the clinicopathological features of our case, along with a review of the few cases present in the literature.
- Published
- 2015
6. Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas
- Author
-
Antonio Solinas and Diego F. Calvisi
- Subjects
Lymphoepithelioma-like carcinoma ,Pathology ,medicine.medical_specialty ,Epstein-Barr Virus Infections ,Lymphoma ,Review ,Cholangiocarcinoma ,Risk Factors ,Carcinoma ,Medicine ,Humans ,Epstein–Barr virus infection ,Intrahepatic Cholangiocarcinoma ,Lymphoepithelioma ,business.industry ,Liver Neoplasms ,Gastroenterology ,General Medicine ,medicine.disease ,Hepatitis C ,digestive system diseases ,Treatment Outcome ,Nasopharyngeal carcinoma ,Hepatocellular carcinoma ,Lymphoepithelioma-Like Hepatocellular Carcinoma ,business - Abstract
In this review we focus on lymphoepithelioma-like hepatocellular carcinomas (LEL-HCC) and lymphoepithelioma-like cholangiocarcinomas (LEL-ICC). Despite their rarity, these tumors are of general interest because of their epidemiological and clinical features, and because they represent a distinct model of interaction between the immune system and neoplastic cells. Approximately half of LEL-HCC arise in the context of chronic hepatitis C virus (HCV) infection and have been described both in Eastern and Western patients. By contrast, LEL-ICC is associated in almost all cases with Epstein-Barr virus (EBV) infection and exhibits the same epidemiological features of EBV related malignancies. Compared with classical hepatocellular carcinoma and intrahepatic cholangiocarcinoma of corresponding stage, both LEL-HCC and LEL-ICC are characterized by lower rates of recurrence after surgery and better overall survival. How this behavior is related to distinct genetic alterations and tumor microenvironment is unclear. The pathophysiological mechanisms of lymphoid infiltrations seem to be different among the two groups of tumors. In fact, LEL-HCC frequently arises in the context of inflammatory changes driven by HCV infection, and has been recognized as a variant of classical hepatocellular carcinoma. At variance, lymphocyte recruitment of LEL-ICC is similar to that described in nasopharyngeal carcinoma and gastric LEL, and possibly depends on the expression pattern of latent EBV infection.
- Published
- 2015
7. Lymphoepithelioma-like hepatocellular carcinoma: a case report with emphasis on the cytological features.
- Author
-
Miyasaka C, Ishida M, Ito H, Kaibori M, Uemura Y, and Tsuta K
- Abstract
Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a rare distinct histopathological subtype of HCC, which is characterized histopathologically by the presence of abundant lymphocytes around the neoplastic cells, and less than 50 cases have been reported. In this report, we describe the first cytological case of LEL-HCC. A 58-year-old Japanese male had an elevated serum alpha-fetoprotein (AFP) level, and computed tomography scan demonstrated a tumorous lesion with contrast enhancement in the liver, thus, surgical resection was performed. The Papanicolaou smear of the liver tumor demonstrated small clusters and trabeculae of large-sized polygonal cells in a background of an abundance of small lymphocytes. These tumor cells had a rich granular cytoplasm and large centrally located round to oval nuclei containing conspicuous nucleoli. Immunocytochemical analyses revealed that these cells were positive for AFP, glypican-3, and Hep-Par1. Histopathological study demonstrated LEL-HCC. The cytological features of the present case represent both lymphoepithelioma-like carcinoma and conventional HCC. The prognosis of LEL-HCC may be favorable. Therefore, the diagnosis of this type of tumor is important, and a cytological examination can provide useful information for diagnosis of LEL-HCC., Competing Interests: None., (IJCEP Copyright © 2017.)
- Published
- 2017
8. Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas.
- Author
-
Solinas A and Calvisi DF
- Subjects
- Carcinoma immunology, Carcinoma mortality, Carcinoma surgery, Carcinoma virology, Cholangiocarcinoma immunology, Cholangiocarcinoma mortality, Cholangiocarcinoma surgery, Cholangiocarcinoma virology, Epstein-Barr Virus Infections complications, Epstein-Barr Virus Infections virology, Hepatitis C complications, Hepatitis C virology, Humans, Liver Neoplasms immunology, Liver Neoplasms mortality, Liver Neoplasms surgery, Liver Neoplasms virology, Lymphoma immunology, Lymphoma mortality, Lymphoma surgery, Lymphoma virology, Risk Factors, Treatment Outcome, Carcinoma pathology, Cholangiocarcinoma pathology, Liver Neoplasms pathology, Lymphoma pathology
- Abstract
In this review we focus on lymphoepithelioma-like hepatocellular carcinomas (LEL-HCC) and lymphoepithelioma-like cholangiocarcinomas (LEL-ICC). Despite their rarity, these tumors are of general interest because of their epidemiological and clinical features, and because they represent a distinct model of interaction between the immune system and neoplastic cells. Approximately half of LEL-HCC arise in the context of chronic hepatitis C virus (HCV) infection and have been described both in Eastern and Western patients. By contrast, LEL-ICC is associated in almost all cases with Epstein-Barr virus (EBV) infection and exhibits the same epidemiological features of EBV related malignancies. Compared with classical hepatocellular carcinoma and intrahepatic cholangiocarcinoma of corresponding stage, both LEL-HCC and LEL-ICC are characterized by lower rates of recurrence after surgery and better overall survival. How this behavior is related to distinct genetic alterations and tumor microenvironment is unclear. The pathophysiological mechanisms of lymphoid infiltrations seem to be different among the two groups of tumors. In fact, LEL-HCC frequently arises in the context of inflammatory changes driven by HCV infection, and has been recognized as a variant of classical hepatocellular carcinoma. At variance, lymphocyte recruitment of LEL-ICC is similar to that described in nasopharyngeal carcinoma and gastric LEL, and possibly depends on the expression pattern of latent EBV infection.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.